Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06422182Completed
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Total morphine consumption at 48 hours. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06422182.